Browsing Tag
Cipla
20 posts
Cipla Limited (NSE: CIPLA) secures FDA approval for generic nintedanib capsules, entering a $3.8bn U.S. pulmonary fibrosis market
Cipla wins FDA approval for generic nintedanib capsules for IPF, targeting Boehringer Ingelheim's $3.76B Ofev market. Here's what the launch means for investors. Read more.
Pharma stock watch: Are Indian midcaps like Glenmark better positioned than the giants?
Are Indian midcap pharma stocks like Glenmark set to outperform giants like Sun and Cipla? Explore 2025 trends, biotech bets, and market sentiment shifts.
NSE’s biggest losers on March 26: NDL Ventures, Salasar Techno Engineering, and others tumble
Indian stock markets reversed their seven-session rally on March 26 as profit-booking and U.S. tariff concerns triggered a sell-off. Find out which stocks were the biggest losers.
Cipla secures exclusive rights to market Formosa Pharmaceuticals’ APP13007 across 11 countries
Cipla Limited has expanded its presence in the ophthalmology market through a multi-regional licensing agreement with Formosa Pharmaceuticals,…
Cipla announces JV with Kemwell Biopharma and Manipal Group for cell therapy development
Cipla (EU) Limited, UK, a wholly-owned subsidiary of Cipla Limited, has entered into a strategic collaboration with Kemwell…
Cipla expands digital healthcare reach with further investment in GoApptiv
Cipla Limited, a leading pharmaceutical company, has announced its decision to further invest approximately INR 42 crore in…
Cipla’s InvaGen Pharmaceuticals recalls Vigabatrin over seal integrity concerns
InvaGen Pharmaceuticals Inc., a wholly-owned subsidiary of Cipla Limited, has announced a voluntary recall of one lot of…
Cipla to acquire Actor Pharma to dominate South African OTC market
In a strategic move that amplifies its commitment to the Over-The-Counter (OTC) business, Cipla South Africa, a 100%…
Cipla launches Cippoint point-of-care testing device in India
Indian pharma company Cipla Limited has launched a point-of-care testing device called Cippoint in India for infectious diseases,…
Cipla receives six observations from FDA for Goa manufacturing facility
Cipla Ltd said that the US Food and Drug Administration (FDA) has concluded an inspection of the company’s…